# Pharmacogenomics: Activating Cancer Drug Discovery

**Authors:** M. Nathaniel Mead

PMC · DOI: 10.1289/ehp.112-1277127 · Environmental Health Perspectives · 2004-08-01

## Full-text entities

- **Genes:** FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}
- **Diseases:** obesity (MESH:D009765), Cancer (MESH:D009369), prostate cancer (MESH:D011471), toxicity (MESH:D064420), weight loss (MESH:D015431), (MESH:D002471)
- **Chemicals:** carbohydrates (MESH:D002241), fat (MESH:D005223), Orlistat (MESH:D000077403), fatty acids (MESH:D005227), palmitate (MESH:D010168), (MESH:D000970), (MESH:D002273)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC1277127/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC1277127/full.md

---
Source: https://tomesphere.com/paper/PMC1277127